松果腺在衰老和阿尔茨海默病中的作用:与年龄相关的分子变化
Meiqi Li1, Hongwei Xie2, Jie Li2
1School of Basic Medical Sciences, Anhui Medical University, Anhui, 230032, China.
Brain structure & function
|January 21, 2026
概括
老龄化的人类桃腺显示渐进的化和细胞损失. 阿尔茨海默病 (AD) 加快了这些变化,增加了粉样β (Aβ) 和减少了黑激素,为AD病理学提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 老年学是一门学科.
背景情况:
- 松果腺经历与年龄相关的退化,影响生理功能.
- 阿尔茨海默氏症 (AD) 与神经病理变化有关,但松果腺的参与程度不太清楚.
研究的目的:
- 为了研究与年龄相关的分子变化和AD相关的病理在人类松果腺.
- 分析与衰老和阿尔茨海默氏病有关的组织病理变化.
主要方法:
- 对54个不同年龄组和AD患者的人类松果腺样本的组织病理学分析.
- 评估化,细胞损失,脂素,囊,GFAP,P-Tau和Aβ沉积的情况.
- 松果变化与年龄,性别和AD状态的相关性;脑脊液中黑激素水平被分析.
主要成果:
- 松果化开始于3岁,随着年龄的增长和细胞损失而增加.
- 观察到的两性变异:雌性表现出脂素/囊;雄性表现出GFAP/结合组织.
- 粉样β (Aβ) 沉积随着年龄的增长而增加,并且在AD中升高;阿尔茨海默病患者表现出桃细胞枯竭和更高的GFAP.
- 在AD队列中发现脑脊液中黑激素水平降低.
结论:
- 人类桃腺表现出与年龄相关的重大病理变化,包括化和细胞损失.
- 阿尔茨海默病加剧松果腺病理,其特征是Aβ沉积增加和细胞枯竭.
- 这些发现突出了松果腺在衰老和AD中的作用,表明了新的治疗策略的潜力.
相关概念视频
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


